1,031 companies
ABCL
AbCellera Biologics Inc
abcellera is a canadian biotechnology company focused on accelerating the discovery of monoclonal antibody (mabs) therapeutics.
British Columbia, Canada
NASDAQ
ABT
Abbott Laboratories
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States.
Illinois
NYSE
ABBV
Abbvie Inc
AbbVie Inc. is a pharmaceutical company headquartered in North Chicago, Illinois.
Illinois
NYSE
ABEO
Abeona Therapeutics Inc
abeona therapeutics inc.
Ohio
NASDAQ
ABVX
Abivax S.A.
NASDAQ
ABP
Abpro Corp
Massachusetts
ACAD
Acadia Pharmaceuticals Inc
acadia pharmaceuticals (nasdaq: acad) is a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in related central nervous system (cns) disorders.
California
NASDAQ
ACST
Acasti Pharma Inc - Ordinary Shares
acasti pharma, inc., a subsiduary of neptune technologies & bioressources, is a quebec-based biopharmaceutical dedicated in advancing a proprietary portfolio based on marine phospholipids.
New Jersey
NASDAQ
ACCP
Accelerated Pharma, Inc.
Illinois
NASDAQ
ACUT
Accustem Sciences Inc.
AccuStem Sciences, Inc.(the “Company”) is a life sciences company focused on improving outcomes for patients with cancer.
New York
OTC
SLRN
Acelyrin Inc
ACELYRIN, INC. (Nasdaq: SLRN) is a Los Angeles area-based late-stage clinical biopharma company – with additional operations in the San Francisco Bay area – focused on providing patients life-changing new treatment options by identifying, acquiring, and accelerating the development and commercialization of transformative medicines.
California
NASDAQ
ACER
Acer Therapeutics Inc.
acer therapeutics is a biotech company, headquartered in cambridge, ma, that develops repurposed and reformulated medicines for the treatment of ultra-orphan diseases with significant unmet medical needs.
Massachusetts
NASDAQ
AKAOQ
Achaogen, Inc.
Achaogen, Inc.
California
NASDAQ
Achillion Pharmaceuticals Inc
We are a clinical-stage biopharmaceutical company focused on advancing our oral small molecule complement system inhibitors into late-stage development and commercialization. Each of the product candidates in our portfolio was discovered in our laboratories and is wholly owned by us. We are focusing our product development activities on complement-mediated diseases where there are no approved therapies or where significant unmet medical need persists despite existing therapies.
Connecticut
ACRS
Aclaris Therapeutics Inc
aclaris therapeutics, inc.
Pennsylvania
NASDAQ
ACRV
Acrivon Therapeutics Inc
acrivon therapeutics is a biotech company specializing in drug development through early clinical treatment success using our unique predictive biomarker approach.
Massachusetts
NASDAQ
RASP
Actavia Life Sciences, Inc.
Rasna Therapeutics, Inc.
New York
OTC
Actavis, Inc.
The investment seeks long-term capital appreciation.
The fund is an actively-managed exchange-traded fund that invests at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from tobacco and alcoholic beverages and companies that derive at least 50% of their net revenue from the marijuana and hemp industry or have at least 50% of their company assets dedicated to lawful research and development of cannabis or cannabinoid-related products.
New Jersey
ATNM
Actinium Pharmaceuticals Inc
actinium pharmaceuticals, inc.
New York
NYSEAMERICAN
ACUR
Acura Pharmaceuticals, Inc
acura pharmaceuticals, inc.
Illinois
NASDAQ